Concepedia

Saul Kivimäe

SK

Statistics

Publications

18

Citations

1.4K

H-Index

18

Active since

2006

Affiliations

University of California, San Francisco(Current)

Nektar Therapeutics (United States)

Howard Hughes Medical Institute

University of California, Berkeley

Saul Kivimäe is an author at University of California, San Francisco specializing in life sciences, pharmacology, and cancer immunotherapy.

Publications per year

2006–2022

18

Publications

18

Glucose Sensor O-GlcNAcylation Coordinates with Phosphorylation to Regulate Circadian Clock

Krista Kaasik, Saul Kivimäe, Jasmina J. Allen et al. · Cell Metabolism · 2013 · 250 citations · Full text

, , +14

DACT3 Is an Epigenetic Regulator of Wnt/β-Catenin Signaling in Colorectal Cancer and Is a Therapeutic Target of Histone Modifications

Xia Jiang, Jing Tan, Jingsong Li et al. · Cancer Cell · 2008 · 238 citations · Full text

, , +17

The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes

Paul H. Kierstead, Hideaki Okochi, Vincent J. Venditto et al. · Journal of Controlled Release · 2015 · 198 citations · Full text

, , +14

Activating PER Repressor through a DBT-Directed Phosphorylation Switch

Saul Kivimäe, Lino Sáez, Michael W. Young · PLoS Biology · 2008 · 86 citations · Full text

, , +16

Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan

Aditya Kohli, Saul Kivimäe, Matthew Tiffany et al. · Journal of Controlled Release · 2014 · 85 citations

, , +12

1–5 of 18